Avricore Health Inc V.AVCR

Alternate Symbol(s): AVCRF

Technology Diagnostics & Research Information Technology Services

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.

TSXV:AVCR - Post by User

Avricore Health Inc

Bullboard Posts

Comment by naimarantzon Jan 16, 2015 9:13am

222 Views

Post# 23327053

RE:RE:Checked out SLXP from what I can gather they are

.....so this well established company is powering over 500 staff plus the costs of R&D and phase trials and still netting $475 million on the sales of only 23 generic drugs. Thanks, that's good information

calenderj wrote: From SLXP website:[Just a little difference]

Sales force more than doubled to >500 specialty sales reps.

Strong IP protection: Orphan Status Designation,

nine Orange Book listed patents, protection to 2029.

They are in different phase trials of some of their own drugs.That's why they are worth what they are worth.